A novel protocol allowing oral delivery of a protein complement inhibitor that subsequently targets to inflamed colon mucosa and ameliorates murine colitis
一种新的方案，允许口服蛋白质补体抑制剂，随后靶向发炎的结肠粘膜并改善小鼠结肠炎
期刊:Clinical and Experimental Immunology
影响因子:3.4
doi:10.1111/cei.12350
M Elvington, P Blichmann, F Qiao, M Scheiber, C Wadsworth, I Luzinov, J Lucero, A Vertegel, S Tomlinson
